{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:01:49Z","timestamp":1791478909817,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG083744"],"award-info":[{"award-number":["RF1AG083744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCI P30CA118100-16"],"award-info":[{"award-number":["NCI P30CA118100-16"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30NS048056"],"award-info":[{"award-number":["P30NS048056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG03991"],"award-info":[{"award-number":["P01AG03991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG03991"],"award-info":[{"award-number":["P01AG03991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG044546"],"award-info":[{"award-number":["R01AG044546"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020153","name":"Centene Corporation","doi-asserted-by":"publisher","award":["(P19-00559) for the Washington University-Centene ARCH Personalized Medicine Initiative"],"award-info":[{"award-number":["(P19-00559) for the Washington University-Centene ARCH Personalized Medicine Initiative"]}],"id":[{"id":"10.13039\/100020153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02043-2","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:45:08Z","timestamp":1778150708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early syndecan-4 upregulation predicts cognitive and pathological trajectories in Alzheimer disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Rawan","family":"Tarawneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Moulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danai G.","family":"Topouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng Tony","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon S.","family":"Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigyasha","family":"Timsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau M.","family":"Ances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie L.S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hassenstab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"2","key":"2043_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/bf02932857","volume":"40","author":"T Miyakawa","year":"1982","unstructured":"Miyakawa T, Shimoji A, Kuramoto R, Higuchi Y. The relationship between senile plaques and cerebral blood vessels in Alzheimer\u2019s disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Archiv B Cell Pathol including Mol Pathol. 1982;40(2):121\u20139. https:\/\/doi.org\/10.1007\/bf02932857.","journal-title":"Virchows Archiv B Cell Pathol including Mol Pathol"},{"key":"2043_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1440-1819.1991.tb00510.x","volume":"45 1","author":"K Araki","year":"1991","unstructured":"Araki K, Miyakawa T, Katsuragi S. Ultrastructure of senile plaque using thick sections in the brain with Alzheimer\u2019s disease. Japanese J psychiatry Neurol. 1991;45 1:85\u20139. https:\/\/doi.org\/10.1111\/j.1440-1819.1991.tb00510.x.","journal-title":"Japanese J psychiatry Neurol"},{"key":"2043_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/bf00294173","volume":"87 5","author":"L Bu\u00e9e","year":"1994","unstructured":"Bu\u00e9e L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, et al. Pathological alterations of the cerebral microvasculature in Alzheimer\u2019s disease and related dementing disorders. Acta Neuropathol. 1994;87 5:469\u201380. https:\/\/doi.org\/10.1007\/bf00294173.","journal-title":"Acta Neuropathol"},{"key":"2043_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00001756-199502000-00018","volume":"6 3","author":"RN Kalaria","year":"1995","unstructured":"Kalaria RN, Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer\u2019s disease. NeuroReport. 1995;6 3:477\u201380. https:\/\/doi.org\/10.1097\/00001756-199502000-00018.","journal-title":"NeuroReport"},{"key":"2043_CR5","first-page":"197","volume":"3 4","author":"RJ Kelleher","year":"2013","unstructured":"Kelleher RJ, Soiza RL. Evidence of endothelial dysfunction in the development of Alzheimer\u2019s disease: Is Alzheimer\u2019s a vascular disorder? Am J Cardiovasc Dis. 2013;3 4:197\u2013226.","journal-title":"Am J Cardiovasc Dis"},{"key":"2043_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s0163-7258(96)00116-7","volume":"72 3","author":"RN Kalaria","year":"1996","unstructured":"Kalaria RN. Cerebral vessels in ageing and Alzheimer\u2019s disease. Pharmacol Ther. 1996;72 3:193\u2013214. https:\/\/doi.org\/10.1016\/s0163-7258(96)00116-7.","journal-title":"Pharmacol Ther"},{"key":"2043_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/brain\/awz011","volume":"142 4","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Shinohara M, Shinohara M, Yamazaki A, Murray ME, Liesinger AM, et al. Selective loss of cortical endothelial tight junction proteins during Alzheimer\u2019s disease progression. Brain. 2019;142 4:1077\u201392. https:\/\/doi.org\/10.1093\/brain\/awz011.","journal-title":"Brain"},{"key":"2043_CR8","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1073\/pnas.0709788105","volume":"105 9","author":"EP Meyer","year":"2008","unstructured":"Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T. Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2008;105 9:3587\u201392. https:\/\/doi.org\/10.1073\/pnas.0709788105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2043_CR9","doi-asserted-by":"publisher","unstructured":"Tarawneh R. Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy? Biomolecules. 2023;13(5). https:\/\/doi.org\/10.3390\/biom13050830.","DOI":"10.3390\/biom13050830"},{"key":"2043_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1749-6632.1997.tb48462.x","volume":"826","author":"JC de la Torre","year":"1997","unstructured":"de la Torre JC. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer\u2019s disease. Ann N Y Acad Sci. 1997;826:75\u201391. https:\/\/doi.org\/10.1111\/j.1749-6632.1997.tb48462.x.","journal-title":"Ann N Y Acad Sci"},{"key":"2043_CR11","doi-asserted-by":"publisher","unstructured":"Lau S-F, Cao H, Fu AKY, Ip NY. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences. 2020;117 41:25800; https:\/\/doi.org\/10.1073\/pnas.2008762117","DOI":"10.1073\/pnas.2008762117"},{"key":"2043_CR12","doi-asserted-by":"publisher","unstructured":"Yang AC, Vest RT, Kern F, Lee DP, Maat CA, Losada PM et al. A human brain vascular atlas reveals diverse cell mediators of Alzheimer\u2019s disease risk. bioRxiv. 2021:2021.04.26.441262; https:\/\/doi.org\/10.1101\/2021.04.26.441262","DOI":"10.1101\/2021.04.26.441262"},{"key":"2043_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-2094-8-26","volume":"8","author":"P Grammas","year":"2011","unstructured":"Grammas P. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer\u2019s disease. J Neuroinflammation. 2011;8:26. https:\/\/doi.org\/10.1186\/1742-2094-8-26.","journal-title":"J Neuroinflammation"},{"key":"2043_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fnagi.2017.00399","volume":"9","author":"R Takechi","year":"2017","unstructured":"Takechi R, Lam V, Brook E, Giles C, Fimognari N, Mooranian A, et al. Blood-Brain Barrier Dysfunction Precedes Cognitive Decline and Neurodegeneration in Diabetic Insulin Resistant Mouse Model: An Implication for Causal Link. Front Aging Neurosci. 2017;9:399. https:\/\/doi.org\/10.3389\/fnagi.2017.00399.","journal-title":"Front Aging Neurosci"},{"key":"2043_CR15","doi-asserted-by":"publisher","first-page":"117727192097636","DOI":"10.1177\/1177271920976367","volume":"15","author":"R Tarawneh","year":"2020","unstructured":"Tarawneh R, Biomarkers. Our Path Towards a Cure for Alzheimer Disease. Biomark Insights. 2020;15:1177271920976367. https:\/\/doi.org\/10.1177\/1177271920976367.","journal-title":"Biomark Insights"},{"key":"2043_CR16","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.3390\/jcm9093051","volume":"9 9","author":"M Lipphardt","year":"2020","unstructured":"Lipphardt M, Dihazi H, Maas J-H, Sch\u00e4fer A-K, Amlaz SI, Ratliff BB, et al. Syndecan-4 as a Marker of Endothelial Dysfunction in Patients with Resistant Hypertension. J Clin Med. 2020;9 9:3051.","journal-title":"J Clin Med"},{"key":"2043_CR17","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.124636","author":"A Elfenbein","year":"2013","unstructured":"Elfenbein A, Simons M. Syndecan-4 signaling at a glance. J Cell Sci. 2013. https:\/\/doi.org\/10.1242\/jcs.124636. 126 Pt 17:3799\u2009\u2013\u2009804.","journal-title":"J Cell Sci"},{"key":"2043_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1369\/0022155415568995","volume":"63 4","author":"TT Vuong","year":"2015","unstructured":"Vuong TT, Reine TM, Sudworth A, Jenssen TG, Kolset SO. Syndecan-4 is a major syndecan in primary human endothelial cells in vitro, modulated by inflammatory stimuli and involved in wound healing. J Histochem Cytochem. 2015;63 4:280\u201392. https:\/\/doi.org\/10.1369\/0022155415568995.","journal-title":"J Histochem Cytochem"},{"key":"2043_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molcel.2008.09.010","volume":"32 1","author":"C Partovian","year":"2008","unstructured":"Partovian C, Ju R, Zhuang ZW, Martin KA, Simons M. Syndecan-4 Regulates Subcellular Localization of mTOR Complex2 and Akt Activation in a PKC\u03b1-Dependent Manner in Endothelial Cells. Mol Cell. 2008;32 1:140\u20139. https:\/\/doi.org\/10.1016\/j.molcel.2008.09.010.","journal-title":"Mol Cell"},{"key":"2043_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/jnen\/nlaa016","volume":"79 5","author":"L Lorente-Gea","year":"2020","unstructured":"Lorente-Gea L, Garc\u00eda B, Mart\u00edn C, Ordiales H, Garc\u00eda-Su\u00e1rez O, Pi\u00f1a-Batista KM, et al. Heparan Sulfate Proteoglycans Undergo Differential Expression Alterations in Alzheimer Disease Brains. J Neuropathol Exp Neurol. 2020;79 5:474\u201383. https:\/\/doi.org\/10.1093\/jnen\/nlaa016.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2043_CR21","doi-asserted-by":"publisher","unstructured":"Snow AD, Cummings JA, Lake T. The Unifying Hypothesis of Alzheimer\u2019s Disease: Heparan Sulfate Proteoglycans\/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago. Front Aging Neurosci. 2021;13. https:\/\/doi.org\/10.3389\/fnagi.2021.710683.","DOI":"10.3389\/fnagi.2021.710683"},{"key":"2043_CR22","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","volume":"43 11","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43 11:2412\u20134. https:\/\/doi.org\/10.1212\/wnl.43.11.2412-a.","journal-title":"Neurology"},{"key":"2043_CR23","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/s0140-6736(94)92557-7","volume":"343 8910","author":"C Talbot","year":"1994","unstructured":"Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer\u2019s disease with apoE epsilon 2. Lancet. 1994;343 8910:1432\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(94)92557-7.","journal-title":"Lancet"},{"key":"2043_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1212\/WNL.0b013e318248e568","volume":"78 10","author":"R Tarawneh","year":"2012","unstructured":"Tarawneh R, Lee JM, Ladenson JH, Morris JC, Holtzman DM. CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology. 2012;78 10:709\u201319. https:\/\/doi.org\/10.1212\/WNL.0b013e318248e568.","journal-title":"Neurology"},{"key":"2043_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","volume":"71 8","author":"MC Donohue","year":"2014","unstructured":"Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014;71 8:961\u201370. https:\/\/doi.org\/10.1001\/jamaneurol.2014.803.","journal-title":"JAMA Neurol"},{"key":"2043_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1037\/neu0000949","volume":"38 5","author":"NS McKay","year":"2024","unstructured":"McKay NS, Millar PR, Nicosia J, Aschenbrenner AJ, Gordon BA, Benzinger TLS, et al. Pick a PACC: Comparing domain-specific and general cognitive composites in Alzheimer disease research. Neuropsychology. 2024;38 5:443\u201364. https:\/\/doi.org\/10.1037\/neu0000949.","journal-title":"Neuropsychology"},{"key":"2043_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/WAD.0b013e3181cfc78b","volume":"24 3","author":"E Grober","year":"2010","unstructured":"Grober E, Sanders AE, Hall C, Lipton RB. Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis Assoc Disord. 2010;24 3:284\u201390. https:\/\/doi.org\/10.1097\/WAD.0b013e3181cfc78b.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2043_CR28","doi-asserted-by":"crossref","unstructured":"Wechsler D. The psychometric tradition: developing the wechsler adult intelligence scale. Contemp Educ Psychol. 1981.","DOI":"10.1016\/0361-476X(81)90035-7"},{"key":"2043_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/h0093567","volume":"60","author":"SG Armitage","year":"1946","unstructured":"Armitage SG. An analysis of certain psychological tests used for the evaluation of brain injury. Psychol Monogr. 1946;60:1.","journal-title":"Psychol Monogr"},{"key":"2043_CR30","volume-title":"BDAE: The Boston diagnostic aphasia examination","author":"H Goodglass","year":"2001","unstructured":"Goodglass H, Kaplan E, Weintraub S. BDAE: The Boston diagnostic aphasia examination. Philadelphia, PA: Lippincott Williams & Wilkins; 2001."},{"key":"2043_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s43587-023-00380-7","volume":"3 4","author":"NR Barth\u00e9lemy","year":"2023","unstructured":"Barth\u00e9lemy NR, Saef B, Li Y, Gordon BA, He Y, Horie K, et al. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer\u2019s disease. Nat Aging. 2023;3 4:391\u2013401. https:\/\/doi.org\/10.1038\/s43587-023-00380-7.","journal-title":"Nat Aging"},{"key":"2043_CR32","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J, Bj\u00f6rkesten J, Assarsson E, Henriksson S, et al. Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis. Mol Cell Proteom. 2021;20:100168. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100168.","journal-title":"Mol Cell Proteom"},{"key":"2043_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622 7982","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-H, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622 7982:329\u201338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6.","journal-title":"Nature"},{"key":"2043_CR34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14 4","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14 4:535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"key":"2043_CR35","doi-asserted-by":"publisher","first-page":"e0152082","DOI":"10.1371\/journal.pone.0152082","volume":"11 3","author":"Y Su","year":"2016","unstructured":"Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, et al. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer\u2019s Disease: Results from the DIAN Study Group. PLoS ONE. 2016;11 3:e0152082. https:\/\/doi.org\/10.1371\/journal.pone.0152082.","journal-title":"PLoS ONE"},{"key":"2043_CR36","doi-asserted-by":"publisher","first-page":"e73377","DOI":"10.1371\/journal.pone.0073377","volume":"8 11","author":"Y Su","year":"2013","unstructured":"Su Y, D\u2019Angelo GM, Vlassenko AG, Zhou G, Snyder AZ, Marcus DS, et al. Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLoS ONE. 2013;8 11:e73377. https:\/\/doi.org\/10.1371\/journal.pone.0073377.","journal-title":"PLoS ONE"},{"key":"2043_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuroimage.2014.11.058","volume":"107","author":"Y Su","year":"2015","unstructured":"Su Y, Blazey TM, Snyder AZ, Raichle ME, Marcus DS, Ances BM, et al. Partial volume correction in quantitative amyloid imaging. NeuroImage. 2015;107:55\u201364.","journal-title":"NeuroImage"},{"key":"2043_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nicl.2018.04.022","volume":"19","author":"Y Su","year":"2018","unstructured":"Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, et al. Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. NeuroImage: Clin. 2018;19:406\u201316. https:\/\/doi.org\/10.1016\/j.nicl.2018.04.022.","journal-title":"NeuroImage: Clin"},{"issue":"1","key":"2043_CR39","first-page":"180","volume":"11","author":"Y Su","year":"2019","unstructured":"Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, et al. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2019;11(1):180\u201390.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"2043_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/jad-122059","volume":"34 2","author":"DT Chien","year":"2013","unstructured":"Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su MY, et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis. 2013;34 2:457\u201368. https:\/\/doi.org\/10.3233\/jad-122059.","journal-title":"J Alzheimers Dis"},{"key":"2043_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neuroimage.2017.07.050","volume":"161","author":"S Mishra","year":"2017","unstructured":"Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, et al. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. NeuroImage. 2017;161:171\u20138. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.07.050.","journal-title":"NeuroImage"},{"issue":"3","key":"2043_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16(3):271\u20138. https:\/\/doi.org\/10.1016\/0197-4580(95)00021-6. discussion 8\u201384.","journal-title":"Neurobiol Aging"},{"key":"2043_CR43","unstructured":"Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. Guilford; 2017."},{"key":"2043_CR44","doi-asserted-by":"publisher","unstructured":"Tasaki S, Xu J, Avey DR, Johnson L, Petyuk VA, Dawe RJ, et al. Inferring protein expression changes from mRNA in Alzheimer\u2019s dementia using deep neural networks. Nat Commun. 2022;13(1:655). https:\/\/doi.org\/10.1038\/s41467-022-28280-1.","DOI":"10.1038\/s41467-022-28280-1"},{"key":"2043_CR45","unstructured":"Cs\u00e1rdi G, Nepusz T. The igraph software package for complex network research. In: InterJournal, Complex Systems,. 2006."},{"key":"2043_CR46","unstructured":"Cs\u00e1rdi G, Nepusz T, Traag V, Horv\u00e1t S, Zanini F, Noom D et al. igraph: Network Analysis and Visualization in R. 2025; doi: doi:10.5281\/zenodo.7682609, R package version 2.1.3. https:\/\/CRAN.R-project.org\/package=igraph"},{"key":"2043_CR47","doi-asserted-by":"publisher","unstructured":"Cannoodt R, Saelens W, Sichien D, Tavernier S, Janssens S, Guilliams M, et al. SCORPIUS improves trajectory inference and identifies novel modules in dendritic cell development. bioRxiv. 2016;079509. https:\/\/doi.org\/10.1101\/079509.","DOI":"10.1101\/079509"},{"key":"2043_CR48","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41587-019-0071-9","volume":"37 5","author":"W Saelens","year":"2019","unstructured":"Saelens W, Cannoodt R, Todorov H, Saeys Y. A comparison of single-cell trajectory inference methods. Nat Biotechnol. 2019;37 5:547\u201354. https:\/\/doi.org\/10.1038\/s41587-019-0071-9.","journal-title":"Nat Biotechnol"},{"key":"2043_CR49","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/ni.3200","volume":"16 7","author":"A Schlitzer","year":"2015","unstructured":"Schlitzer A, Sivakamasundari V, Chen J, Sumatoh HRB, Schreuder J, Lum J, et al. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. Nat Immunol. 2015;16 7:718\u201328. https:\/\/doi.org\/10.1038\/ni.3200.","journal-title":"Nat Immunol"},{"key":"2043_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: In: Springer-; 2016."},{"key":"2043_CR51","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9 1","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9 1:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinformatics"},{"key":"2043_CR52","doi-asserted-by":"publisher","first-page":"i161","DOI":"10.1093\/bioinformatics\/btp211","volume":"25 12","author":"TA Knijnenburg","year":"2009","unstructured":"Knijnenburg TA, Wessels LF, Reinders MJ, Shmulevich I. Fewer permutations, more accurate P-values. Bioinformatics. 2009;25 12:i161\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btp211.","journal-title":"Bioinformatics"},{"issue":"D1","key":"2043_CR53","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312. https:\/\/doi.org\/10.1093\/nar\/gkaa1074.","journal-title":"Nucleic Acids Res"},{"key":"2043_CR54","doi-asserted-by":"publisher","unstructured":"van der Ende EL, In \u2018t Veld S, Hanskamp I, van der Lee S, Dijkstra JIR, Hok AHYS, et al. CSF proteomics in autosomal dominant Alzheimer\u2019s disease highlights parallels with sporadic disease. Brain. 2023;146(11):4495\u2013507. https:\/\/doi.org\/10.1093\/brain\/awad213.","DOI":"10.1093\/brain\/awad213"},{"issue":"48","key":"2043_CR55","doi-asserted-by":"publisher","first-page":"17308","DOI":"10.1073\/pnas.1413725111","volume":"111","author":"N Baeyens","year":"2014","unstructured":"Baeyens N, Mulligan-Kehoe MJ, Corti F, Simon DD, Ross TD, Rhodes JM, et al. Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling. Proc Natl Acad Sci. 2014;111(48):17308\u201313. https:\/\/doi.org\/10.1073\/pnas.1413725111.","journal-title":"Proc Natl Acad Sci"},{"key":"2043_CR56","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-024-07493-y","volume":"632 8025","author":"T W\u00e4lchli","year":"2024","unstructured":"W\u00e4lchli T, Ghobrial M, Schwab M, Takada S, Zhong H, Suntharalingham S, et al. Single-cell atlas of the human brain vasculature across development, adulthood and disease. Nature. 2024;632 8025:603\u201313. https:\/\/doi.org\/10.1038\/s41586-024-07493-y.","journal-title":"Nature"},{"key":"2043_CR57","doi-asserted-by":"publisher","first-page":"109508","DOI":"10.1016\/j.celrep.2021.109508","volume":"36 6","author":"B Diaz-Castro","year":"2021","unstructured":"Diaz-Castro B, Bernstein AM, Coppola G, Sofroniew MV, Khakh BS. Molecular and functional properties of cortical astrocytes during peripherally induced neuroinflammation. Cell Rep. 2021;36 6:109508. https:\/\/doi.org\/10.1016\/j.celrep.2021.109508.","journal-title":"Cell Rep"},{"key":"2043_CR58","doi-asserted-by":"publisher","unstructured":"Avalos AM, Valdivia AD, Mu\u00f1oz N, Herrera-Molina R, Tapia JC, Lavandero S et al. Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with alphavbeta3 integrin that activates PKCalpha and RhoA. J Cell Sci 2009;122 Pt 19:3462\u201371; https:\/\/doi.org\/10.1242\/jcs.034827","DOI":"10.1242\/jcs.034827"},{"key":"2043_CR59","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ana.22448","volume":"70 2","author":"R Tarawneh","year":"2011","unstructured":"Tarawneh R, D\u2019Angelo G, Macy E, Xiong C, Carter D, Cairns NJ, et al. Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease. Ann Neurol. 2011;70 2:274\u201385. https:\/\/doi.org\/10.1002\/ana.22448.","journal-title":"Ann Neurol"},{"key":"2043_CR60","doi-asserted-by":"publisher","unstructured":"St-Onge F, Chapleau M, Breitner JCS, Villeneuve S, Pichet Binette A, Initiative ftAsDN. Tau accumulation and its spatial progression across the Alzheimer\u2019s disease spectrum. Brain Commun. 2024;6(1). https:\/\/doi.org\/10.1093\/braincomms\/fcae031.","DOI":"10.1093\/braincomms\/fcae031"},{"key":"2043_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.10.24301099","author":"AM Wojtas","year":"2024","unstructured":"Wojtas AM, Dammer EB, Guo Q, Ping L, Shantaraman A, Duong DM, et al. Proteomic Changes in the Human Cerebrovasculature in Alzheimer\u2019s Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal Fluid. medRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.01.10.24301099.","journal-title":"medRxiv"},{"key":"2043_CR62","doi-asserted-by":"publisher","first-page":"516028","DOI":"10.1155\/2014\/516028","volume":"2014","author":"GL Zhang","year":"2014","unstructured":"Zhang GL, Zhang X, Wang XM, Li JP. Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer\u2019s disease. Biomed Res Int. 2014;2014:516028. https:\/\/doi.org\/10.1155\/2014\/516028.","journal-title":"Biomed Res Int"},{"key":"2043_CR63","doi-asserted-by":"publisher","unstructured":"Zhu Y, Gandy L, Zhang F, Liu J, Wang C, Blair LJ, et al. Heparan Sulfate Proteoglycans in Tauopathy. Biomolecules. 2022;12(12). https:\/\/doi.org\/10.3390\/biom12121792.","DOI":"10.3390\/biom12121792"},{"key":"2043_CR64","doi-asserted-by":"publisher","unstructured":"Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proceedings of the National Academy of Sciences. 2013;110 33:E3138-E47; doi: https:\/\/doi.org\/10.1073\/pnas.1301440110","DOI":"10.1073\/pnas.1301440110"},{"key":"2043_CR65","doi-asserted-by":"publisher","first-page":"603052","DOI":"10.4061\/2011\/603052","volume":"2011","author":"JV Rushworth","year":"2010","unstructured":"Rushworth JV, Hooper NM. Lipid Rafts: Linking Alzheimer\u2019s Amyloid-\u03b2 Production, Aggregation, and Toxicity at Neuronal Membranes. Int J Alzheimer\u2019s Dis. 2010;2011:603052. https:\/\/doi.org\/10.4061\/2011\/603052.","journal-title":"Int J Alzheimer\u2019s Dis"},{"key":"2043_CR66","doi-asserted-by":"publisher","unstructured":"Hud\u00e1k A, Kusz E, Domonkos I, J\u00f3svay K, Kodamullil AT, Szil\u00e1k L, et al. Contribution of syndecans to cellular uptake and fibrillation of \u03b1-synuclein and tau. Sci Rep. 2019;9(1:16543). https:\/\/doi.org\/10.1038\/s41598-019-53038-z.","DOI":"10.1038\/s41598-019-53038-z"},{"key":"2043_CR67","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s0197-4580(02)00010-6","volume":"23 4","author":"J van Horssen","year":"2002","unstructured":"van Horssen J, Kleinnijenhuis J, Maass CN, Rensink AA, Otte-H\u00f6ller I, David G, et al. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging. 2002;23 4:537\u201345. https:\/\/doi.org\/10.1016\/s0197-4580(02)00010-6.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2043_CR68","doi-asserted-by":"publisher","first-page":"C893","DOI":"10.1152\/ajpcell.00247.2022","volume":"324","author":"I Ozsan McMillan","year":"2023","unstructured":"Ozsan McMillan I, Li JP, Wang L. Heparan sulfate proteoglycan in Alzheimer\u2019s disease: aberrant expression and functions in molecular pathways related to amyloid-\u03b2 metabolism. Am J Physiol Cell Physiol. 2023;324(4):C893\u2013909. https:\/\/doi.org\/10.1152\/ajpcell.00247.2022.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2043_CR69","doi-asserted-by":"publisher","first-page":"804702","DOI":"10.3389\/fnmol.2022.804702","volume":"15","author":"K Nazere","year":"2022","unstructured":"Nazere K, Takahashi T, Hara N, Muguruma K, Nakamori M, Yamazaki Y, et al. Amyloid Beta Is Internalized via Macropinocytosis, an HSPG- and Lipid Raft-Dependent and Rac1-Mediated Process. Front Mol Neurosci. 2022;15:804702. https:\/\/doi.org\/10.3389\/fnmol.2022.804702.","journal-title":"Front Mol Neurosci"},{"key":"2043_CR70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/13506129.2013.879643","volume":"21 2","author":"P O\u2019Callaghan","year":"2014","unstructured":"O\u2019Callaghan P, Noborn F, Sehlin D, Li JP, Lannfelt L, Lindahl U, et al. Apolipoprotein E increases cell association of amyloid-\u03b2 40 through heparan sulfate and LRP1 dependent pathways. Amyloid. 2014;21 2:76\u201387. https:\/\/doi.org\/10.3109\/13506129.2013.879643.","journal-title":"Amyloid"},{"key":"2043_CR71","doi-asserted-by":"publisher","unstructured":"Hussong SA, Banh AQ, Van Skike CE, Dorigatti AO, Hernandez SF, Hart MJ, et al. Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy. Nat Commun. 2023;14(1:2367). https:\/\/doi.org\/10.1038\/s41467-023-37840-y.","DOI":"10.1038\/s41467-023-37840-y"},{"key":"2043_CR72","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1161\/circresaha.116.309927","volume":"119 10","author":"C Iadecola","year":"2016","unstructured":"Iadecola C. Untangling Neurons With Endothelial Nitric Oxide. Circ Res. 2016;119 10:1052\u20134. https:\/\/doi.org\/10.1161\/circresaha.116.309927.","journal-title":"Circ Res"},{"key":"2043_CR73","doi-asserted-by":"publisher","unstructured":"Hoglund Z, Ruiz-Uribe N, del Sastre E, Woost B, Bader E, Bailey J, et al. Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer\u2019s disease. Acta Neuropathol. 2024;147(1:101). https:\/\/doi.org\/10.1007\/s00401-024-02751-9.","DOI":"10.1007\/s00401-024-02751-9"},{"key":"2043_CR74","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1001\/archneur.58.9.1395","volume":"58 9","author":"JL Price","year":"2001","unstructured":"Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol. 2001;58 9:1395\u2013402. https:\/\/doi.org\/10.1001\/archneur.58.9.1395.","journal-title":"Arch Neurol"},{"issue":"1","key":"2043_CR75","doi-asserted-by":"publisher","first-page":"fcaa007","DOI":"10.1093\/braincomms\/fcaa007","volume":"2","author":"PS Insel","year":"2020","unstructured":"Insel PS, Mormino EC, Aisen PS, Thompson WK, Donohue MC. Neuroanatomical spread of amyloid \u03b2 and tau in Alzheimer\u2019s disease: implications for primary prevention. Brain Commun. 2020;2(1):fcaa007. https:\/\/doi.org\/10.1093\/braincomms\/fcaa007.","journal-title":"Brain Commun"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02043-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02043-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02043-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:15:57Z","timestamp":1781795757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02043-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2043"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02043-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies were approved by the Human Research Protection Office at Washington University. The research was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DGT, AK and HTQ (who contributed to the statistical analyses pertaining to the biomarker models) are employed by Olink Proteomics (Data Science), part of ThermoFisher Scientific. They were not involved in study design or the generation of the CSF proteomics data. Potential conflicts of interest outside of the submitted work: RT has served as an Editorial Board member of the Neurology journal (unpaid) and Associate Editor of the Biomarker Insights journal (paid). RT currently serves as Editorial Board Member of the NeuroMarkers journal (unpaid). As of Aug 2025, RT has received payments from Springer Nature Switzerland for editorial work on the book \u201cBiomarkers of Neurodegenerative Disorders: Current Progress and Future Directions\u201d. RT has pending (submitted) patent applications related to biomarkers of brain endothelial injury. SES has served on scientific advisory boards on biomarker testing and education for Eisai and Novo Nordisk and has received speaking fees for presentations on biomarker testing from Eisai, Eli Lilly, and Novo Nordisk. TLSB has received grants or contracts from Siemens paid to her institution, consulting fees from Biogen, Eli Lilly, Eisai, Bristol Myers Squibb, J&J, and Merck and has received technology transfer and precursors for radiopharmaceuticals from Avid Radiopharmaceuticals\/Eli Lilly, LMI, and Lantheus, and a scanner loan from Hyperfine to her institution. TLSB has received payment for CME activity from Medscape, PeerView, and Neurology Today, and travel reimbursement from Cedars Sinai Medical Center, Hong Kong Neurological Association and the Alzheimer\u2019s Association. TLSB reports the following patents planned, issued or pending: US patent 16\/097, 457 (Diffusion Basis Spectrum Imaging (DBSI): A Novel Diffusion Method Used to Quantify Neuroinflammation and Predict Alzheimer Disease Progression), and US Patent 12-016-701 (Quantitative Differentiation of Tumor Heterogeneity Using Diffusion MR Imaging Data). TLSB has participated in a Data Safety Monitoring Board or Advisory Board of Siemens and served as an external advisor for NIH-funded studies (no payments). TLSB has served as the co-chair of ASNR Alzheimer\u2019s, ARIA and Dementia Study Group, and RSNA Quantitative Imaging Committee (QuIC) (all unpaid). TLSB has served as a committee member of the American College of Radiology\/ALZ NET imaging, NIH CNN Study Section Chair, and had a leadership or fiduciary role in the ACR Commission on Neurology (all unpaid). JH is a paid consultant for AlzPath, Quanterix, and Prothena. DMH co-founded, has equity, and is on the scientific advisory board of C2N Diagnostics. DMH is on the scientific advisory boards of Denali, Genentech, Cajal Neuroscience, and Switch Therapeutics and consults for Roche and Pfizer. CC has received research support from GSK and Eisai. CC is a member of the scientific advisory board of Circular Genomics and owns stocks in that company. CC is a member of the scientific advisory board of ADmit CC and has served on scientific advisory boards for GSK and Novo Nordisk. All other authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}